Latest filing published 08 Dec 2017 for PharMerica CORP, €2.2M.
Robert A. McKay discloses dealings in PharMerica Corp to SEC (Form 4). In total, 15 filings cover trades dated from 4 March 2016 to 7 December 2017.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 8 December 2017 came the latest disclosure, a transaction for €2.2M in PharMerica Corp. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations